Upharmacia November 2017 | Page 7

Upharmacia November 2017 Yuria-Pharm is a Ukrainian leading producer of infusion solutions. In 9M2017, the company was a #1 supplier on the Ukrainian hospital drug market with 10% market share. On the retail drug market, the company held 10th position. A ntimonopoly B ody fined S anofi -A ventis U kraine and two distributors Antimonopoly Committee of Ukraine fined Sanofi-Aventis Ukraine and Ukrainian distributors BaDM and Optima-Pharm for about UAH 139 mio. The authority fined that during 2010-2011 the companies introduced special conditions for sales and discounts, stimulating the distribution of Sanofi’s drug, which had lost patent protection and had many substitutes. Thus, according to Antimonopoly Committee, three companies were restricting competition from the side of cheaper generic drugs. Sanofi-Aventis Ukraine declared the intention to appeal against the decision in court. “The decision of the Committee creates a precedent that extends the prohibition of antimonopoly legislation to market behavior, which until now was considered legitimate,” the company’s statement said. REGULATORY UPDATES C hanges to the N ational L ist W ill B e M ade T his Y ear On Nov 17, the Draft Resolution of the Cabinet of Ministers of Ukraine was published for public discussion on the website of the Ministry of Health of Ukraine. The resolution proposes to supplement the National List of Essential Medicines approved by Resolution of the Government No. 333 on March 25th, 2009, with new positions. The project was developed in accordance with the recently adopted amendments to the Regulations on the National List of Essential Medicines and the Regulations on the Expert Committee on the Selection and Use of Essential Medicines. Thus, the Expert Committee on the Selection and Use of Essential Medicines conducted an analysis of clinical efficacy and safety of medicinal products confirmed by evidence-based medicine (without pharmacoeconomic analysis) recommended for inclusion in the National List of Essential Medicines www.upharma-c.com in the "fast-track" procedure. After the approval of the draft resolution of the Cabinet of Ministers of Ukraine, the National List in the revised edition will form basis for public procurement in 2018. Subsequently, the National List will be supplemented with new positions based on applications of individuals and legal entities, in particular, holders of registration certificates, on the results of their consideration by the Expert Committee. Applications are accepted throughout the calendar year. T he P lan of M easures for R ealization of the R eform C oncept for F inancing H ealthcare Decree of the Cabinet of Ministers of Ukraine No. 821-p as of Nov 15, 2017 approved the Plan of Measures for the Implementation of the Reform Concept for Financing Provided by Healthcare up to 2020. The Concept itself was approved at the end of 2016 in order to create and implement a new financing model that provides clear and transparent guarantees regarding the amount of free medical care, better financial protection of citizens in case of illness, effective and equitable distribution of public funds and reduction of informal payments, creation of incentives for improving the quality of medical care provision to the population by state and municipal healthcare institutions. Among other things, it is anticipated that in early 2018 an electronic system for the international classification of requests for primary medical care ICPC-2 will be implemented, electronic prescriptions for drugs will be issued, the cost of which will be reimbursed by the state. In addition, in the near future, the introduction of an electronic too